Omeprazole and Sodium Bicarbonate (Aurolife Pharma, LLC)
Welcome to the PulseAid listing for the Omeprazole and Sodium Bicarbonate drug offered from Aurolife Pharma, LLC. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurolife Pharma, LLC |
| NON-PROPRIETARY NAME: | Omeprazole and Sodium Bicarbonate |
| SUBSTANCE NAME: | OMEPRAZOLE; SODIUM BICARBONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-11-21 |
| END MARKETING DATE: | 0000-00-00 |
Omeprazole and Sodium Bicarbonate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Omeprazole and Sodium Bicarbonate from Aurolife Pharma, LLC |
| LABELER NAME: | Aurolife Pharma, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 1100(mg/1; mg/1) |
| START MARKETING DATE: | 2016-11-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13107-115_1e3a3321-fd27-4b56-8690-933d0c8738b9 |
| PRODUCT NDC: | 13107-115 |
| APPLICATION NUMBER: | ANDA204922 |
Other OMEPRAZOLE; SODIUM BICARBONATE Pharmaceutical Manufacturers / Labelers:
